Comparison of creatinine and cystatin C for estimation of glomerular filtration rate in pediatric patients after Fontan operation.


Journal

Congenital heart disease
ISSN: 1747-0803
Titre abrégé: Congenit Heart Dis
Pays: United States
ID NLM: 101256510

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 06 02 2019
revised: 11 03 2019
accepted: 03 04 2019
pubmed: 18 4 2019
medline: 25 2 2020
entrez: 18 4 2019
Statut: ppublish

Résumé

There are several limitations when using creatinine to estimate glomerular filtration rate, especially in children with chronic medical conditions who are at high risk of kidney dysfunction. Cystatin C has been the recent focus of research as a replacement biomarker for creatinine. Our objective was to compare the 2 biomarkers in pediatric single-ventricle heart disease patients who have undergone the Fontan operation. We hypothesized that there would be poor correlation and agreement between the 2 estimates of renal function. This was a single center retrospective chart review of 20 patients who had previously undergone Fontan operation. Demographic and clinical data were collected from medical records. Blood samples were collected as part of routine clinical care and simultaneously measured for serum creatinine and cystatin C. Glomerular filtration rate was calculated using the creatinine-based bedside Schwartz formula and cystatin C-based Zapatelli equation. Spearman correlation and Bland-Altman analysis were used to assess correlation and agreement. The median Schwartz-derived estimated glomerular filtration rate was 98.94 mL/min/1.73 m The bedside Schwartz formula may be an overestimate of glomerular filtration rate in pediatric single-ventricle heart disease patients who have undergone the Fontan operation. While larger studies are necessary, cystatin C is a promising biomarker to replace creatinine and better estimate kidney function in this population.

Sections du résumé

BACKGROUND BACKGROUND
There are several limitations when using creatinine to estimate glomerular filtration rate, especially in children with chronic medical conditions who are at high risk of kidney dysfunction. Cystatin C has been the recent focus of research as a replacement biomarker for creatinine. Our objective was to compare the 2 biomarkers in pediatric single-ventricle heart disease patients who have undergone the Fontan operation. We hypothesized that there would be poor correlation and agreement between the 2 estimates of renal function.
METHODS METHODS
This was a single center retrospective chart review of 20 patients who had previously undergone Fontan operation. Demographic and clinical data were collected from medical records. Blood samples were collected as part of routine clinical care and simultaneously measured for serum creatinine and cystatin C. Glomerular filtration rate was calculated using the creatinine-based bedside Schwartz formula and cystatin C-based Zapatelli equation. Spearman correlation and Bland-Altman analysis were used to assess correlation and agreement.
RESULTS RESULTS
The median Schwartz-derived estimated glomerular filtration rate was 98.94 mL/min/1.73 m
CONCLUSION CONCLUSIONS
The bedside Schwartz formula may be an overestimate of glomerular filtration rate in pediatric single-ventricle heart disease patients who have undergone the Fontan operation. While larger studies are necessary, cystatin C is a promising biomarker to replace creatinine and better estimate kidney function in this population.

Identifiants

pubmed: 30993817
doi: 10.1111/chd.12776
doi:

Substances chimiques

Biomarkers 0
Cystatin C 0
Creatinine AYI8EX34EU

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

760-764

Subventions

Organisme : NIH K08 Career Development Award

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Références

Esch JJ, Salvin JM, Thiagarajan RR, Pedro J, Rajagopal SK. Acute kidney injury after Fontan completion: risk factors and outcomes. J Thorac Cardiovasc Surg. 2015;150(1):190-197.
Patterson T, Hehir DA, Buelow M, et al. Hemodynamic profile of acute kidney injury following the fontan procedure: impact of renal perfusion pressure. World J Pediatr Congenit Heart Surg. 2017;8(3):367-375.
Patel S, Kwiatkowski D, Andrei A, et al. Prevalence and risk factors associated with chronic kidney disease in patients with single ventricle congenital heart disease after fontan palliation. J Am Coll Cardiol. 2017;69(11 suppl): poster 586.
Bacchetta J, Cochat P, Rognant N, Ranchin B, Hadj-Aissa A, Dubourg L. Which creatinine and cystatin C equations can be reliably used in children? Clin J Am Soc Nephrol. 2011;6(3):552-560.
Coca SG, Yalavarthy R, Concato J, Parikh CR. Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review. Kidney Int. 2008;73(9):1008-1016.
Filler G, Bökenkamp A, Hofmann W, Le Bricon T, Martínez-Brú C, Grubb A. Cystatin C as a marker of glomerular filtration rate-history, indications, and future research. Clin Biochem. 2005;38(1):1-8.
Lee J, Hahn W, Ahn J, Chang J, Bae C. Serum cystatin C during 30 postnatal days is dependent on the postconceptional age in neonates. Pediatr Nephrol. 2013;28(7):1073-1078.
Abdelaal NA, Shalaby SA, Khashana AK, Abdelwahab AM. Serum cystatin C as an earlier predictor of acute kidney injury than serum creatinine in preterm neonates with respiratory distress syndrome. Saudi J Kidney Dis Transpl. 2017;28(5):1003-1014.
Ataei N, Bazargani B, Ameli S, et al. Early detection of acute kidney injury by serum cystatin C in critically ill children. Pediatr Nephrol. 2014;29(1):133-138.
Roos JF, Doust J, Tett SE, Kirkpatrick CM. Diagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children-a meta-analysis. Clin Biochem. 2007;40(5-6):383-391.
Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis. 2002;40(2):221-226.
Fox JA, Dudley AG, Bates C, Cannon GM Jr. Cystatin C as a marker of early renal insufficiency in children with congenital neuropathic bladder. J Urol. 2014;191(5):1602-1607.
VITROS chemistry products CREA slides. Rochester, NY: Orthor-Clinical Diagnostics Inc; 2011.
Schwartz GJ, Work DF. Measurement and estimation of GFR in children and adolescents. Clin J Am Soc Nephrol. 2009;4(11):1832-1843.
Zappitelli M, Parvex P, Joseph L, et al. Derivation and validation of cystatin C-based prediction equations for GFR in children. Am J Kidney Dis. 2006;48(2):221-230.
Pottel H, Dubourg L, Goffin K, Delanaye P. Alternatives for the bedside Schwartz equation to estimate glomerular filtration rate in children. Adv Chronic Kidney Dis. 2018;25(1):57-66.
Nehus EJ, Laskin BL, Kathman TI, Bissler JJ. Performance of cystatin C-based equations in a pediatric cohort at high risk of kidney injury. Pediatr Nephrol. 2013;28(3):453-461.
Shlipak MG, Matsushita K, Ärnlöv J, et al. Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med. 2013;369(10):932-943.
Avitabile CM, Leonard MB, Zemel BS, et al. Lean mass deficits, vitamin D status and exercise capacity in children and young adults after Fontan palliation. Heart. 2014;100(21):1702-1707.
Hasson DC, Brinton JT, Cowherd E, Soranno DE, Gist KM. Risk factors for recurrent acute kidney injury in children who undergo multiple cardiac surgeries: a retrospective analysis. Ped Crit Care Med. 2019.
Wilson TG, d'Udekem Y, Winlaw DS, et al. Hepatic and renal end-organ damage in the fontan circulation: a report from the australian and new zealand fontan registry. Int J Cardiol. 2018;273:100-107.
Sharma S, Ruebner RL, Furth SL, Dodds KM, Rychik J, Goldberg DJ. Assessment of kidney function in survivors following fontan palliation. Congenit Heart Dis. 2016;11(6):630-636.
Opotowsky AR, Baraona FR, Mc Causland FR, et al. Estimated glomerular filtration rate and urine biomarkers in patients with single-ventricle fontan circulation. Heart. 2017;103(6):434-442.

Auteurs

Danielle Kirelik (D)

George Washington University School of Medicine, Washington, DC.
Section of Pediatric Cardiology, Department of Pediatrics, University of Colorado, Children's Hospital Colorado, Aurora, Colorado.

Mark Fisher (M)

Section of Pediatric Cardiology, Department of Pediatrics, University of Colorado, Children's Hospital Colorado, Aurora, Colorado.

Michael DiMaria (M)

Section of Pediatric Cardiology, Department of Pediatrics, University of Colorado, Children's Hospital Colorado, Aurora, Colorado.

Danielle E Soranno (DE)

Section of Pediatric Nephrology, Department of Pediatrics, University of Colorado, Children's Hospital Colorado, Aurora, Colorado.

Katja M Gist (KM)

Section of Pediatric Cardiology, Department of Pediatrics, University of Colorado, Children's Hospital Colorado, Aurora, Colorado.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH